TransMedics (TMDX) Liabilities and Shareholders Equity (2018 - 2026)
TransMedics (TMDX) posted quarterly Liabilities and Shareholders Equity of $1.4 billion for Q1 2026, up 71.32% year-over-year from $837.5 million in Q1 2025, and up 34.3% quarter-over-quarter from $1.1 billion in Q4 2025.
TransMedics (TMDX) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
TransMedics' Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 71.32% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $4.3 billion (up 36.22% YoY), while the FY2025 annual figure was $1.1 billion, up 32.87% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $1.4 billion, up from $1.1 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $1.4 billion in Q1 2026, with the low at $117.3 million in Q2 2022.
- The 5-year median for Liabilities and Shareholders Equity is $723.8 million (2024), against an average of $671.5 million.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity slipped 16.53% in 2022, then surged 488.62% in 2023.
- TransMedics' Liabilities and Shareholders Equity stood at $277.1 million in 2022, then surged by 154.76% to $706.0 million in 2023, then increased by 13.88% to $804.1 million in 2024, then jumped by 32.87% to $1.1 billion in 2025, then jumped by 34.3% to $1.4 billion in 2026.
- Business Quant data shows TMDX's Liabilities and Shareholders Equity at $1.4 billion in Q1 2026, $1.1 billion in Q4 2025, and $946.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 10.74 Bn |
| 10 | TransMedics | 3.28 Bn | 2.80 Bn | 113.20 Mn | 1.46 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.46 Bn |
| Mar 31, 2026 | 1.43 Bn |
| Dec 31, 2025 | 1.07 Bn |
| Sep 30, 2025 | 946.03 Mn |
| Jun 30, 2025 | 890.52 Mn |
| Mar 31, 2025 | 837.53 Mn |
| Dec 31, 2024 | 804.08 Mn |
| Sep 30, 2024 | 785.57 Mn |
| Jun 30, 2024 | 758.58 Mn |
| Mar 31, 2024 | 723.83 Mn |
| Dec 31, 2023 | 706.05 Mn |
| Sep 30, 2023 | 689.23 Mn |
| Jun 30, 2023 | 690.36 Mn |
| Mar 31, 2023 | 287.09 Mn |
| Dec 31, 2022 | 277.15 Mn |
| Sep 30, 2022 | 274.87 Mn |
| Jun 30, 2022 | 117.29 Mn |
| Mar 31, 2022 | 124.01 Mn |
| Dec 31, 2021 | 134.89 Mn |
| Sep 30, 2021 | 131.15 Mn |